Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Hydroxyurea Solution in Children with Sickle Cell Anemia
NCT03763656Phase 2Completed
- Sponsor
- Nova Laboratories
- Start
- Jan 2019
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, open-label, single-arm trial of hydroxyurea in sickle cell anemia (SCA), sponsored by Nova Laboratories. Primary endpoints: Apparent Clearance, Apparent Volume of Distribution and 4 more. Started Jan 2019; status: completed.
02
Drugs
hydroxyurea
03
Conditions
sickle cell anemia (SCA)
Beyond the preview
Go deeper on NCT03763656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03763656.